Spatial heterogeneity in glioblastoma: linking single-cell and spatial multi-omics to vaccine immunotherapy
Glioblastoma (GBM) remains the most lethal primary brain tumor, with survival still limited despite advances in multimodal treatment. The tumor’s profound heterogeneity--across patients, within individual tumors, and over time--has frustrated every class of therapeutic intervention. Recent developments in single-cell a...